Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants

Virus Research

Volumn 52, Issue 2, 1997, Pages 183-194

  Butchaiah, G ^a,c   Morgan, D O ^b  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^c INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Antigenic sites; FMDV type Asia 1; nMAb resistant variants

Indexed keywords

NEUTRALIZING ANTIBODY;

ANIMAL CELL; ARTICLE; FOOT AND MOUTH DISEASE VIRUS; IMMUNODIFFUSION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEROTYPE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; APHTHOVIRUS; ASIA; BINDING SITES; CELL LINE; CRICETINAE; EPITOPES, B-LYMPHOCYTE; NEUTRALIZATION TESTS; VARIATION (GENETICS);

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; RNA VIRUSES;

EID: 0031450231     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00117-2     Document Type: Article

References (52)

1. Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D., Brown, F., 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature (London) 337, 709-716.
2. Ansell, D.M., Samuel, A.R., Carpenter, W.C., Knowles, N.J., 1994. Genetic relationships between foot-and-month disease type Asia-1 vrius. Epidemiol. Infect. 12, 213-224.
3. Bachrach, H.L., 1977. Foot-and-mouth disease virus: properties, molecular biology, and immunogenicity. In: Romberger, J.A. (Ed.), Beltsville Symposia in Agricultural Research I. Virology in Agriculture. Allanheld, Osmun, Montclair, pp. 3-32.
4. Bachrach, H.L., Moore, D.M., McKercher, P.D., Polatnick, J., 1975. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J. Immunol. 115, 1636-1641.
5. Bachrach, H.L., Morgan, D.O., McKercher, P.D., Moore, D.M., Robertson, B.H., 1982. Foot-and-mouth disease virus: Immunogenicity and structure of fragments derived from capsid protein VP3 and of virus containing cleaved VP3. Vet. Microbiol. 7, 85-96.
6. Bachrach, H.L., Morgan, D.O., Moore, D.M., 1979. Foot-and-mouth disease virus immunogenic capsid protein VPT: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavages. Intervirology 12, 65-72.
7. Bachrach, H.L., Trautman, R., Breese, S.S., 1964. Chemical and physical properties of virtually pure foot-and-mouth disease virus. Am. J. Vet. Res. 25, 333-342.
8. Barnett, P.V., Ouldridge, E.J., Rowlands, D.J., Brown, F., Parry, N.R., 1989. Neutralizing epitopes of type-O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J. Gen. Virol. 70, 1438-1491.
9. Baxt, B., Bachrach, H.L., 1982. The adsorption and degradation of foot-and-mouth disease virus by isolated BHK-21 cell plasma membranes. Virology 116, 391-405.
10. Baxt, B., Vakharia, V., Moore, D.M., Franke, A.J., Morgan, D.O., 1989. Analysis of neutralizing antigenic sites on the surface of the type A12 foot-and-mouth disease virus. J. Virol. 63, 2143-2151.
11. Bittle, J.L., Houghten, R.A., Alexander, H., Shinnick, T.M., Sutcliffe, J.G., Lerner, R.A., Rowlands, D.J., Brown, F., 1982. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucletoide sequence. Nature (London) 298, 30-33.
12. Blondel, B., Crainic, R., Fichot, O., Dufraisse, G., Candrea, A., Diamond, D., Girard, M., Horaud, F., 1986. Mutations conferring resistance to neutralization with monoclonal antiodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J. Virol. 57, 81-90.
13. Booth, J.C., Rweyemamu, M.M., Pay, T.W.F., 1978. Dose-response relationships in a microneutralization test for foot-and-mouth disease viruses. J. Hyg. Camb. 80, 31-42.
14. Broekhuijsen, M., Van Rijn, J.M.M., Blom, A.J.M., Pouwels, P.M., Enger-Valk, B.E., Brown, F., Francis, M.J., 1987. Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals. J. Gen. Virol. 68, 3137-3143.
15. Butchaiah, G., Card, J.L., Morgan, D.O., 1992. Antigenic relationships of foot-and-mouth disease virus serotype Asia-1 isolates demonstrated by monoclonal antibodies. Vet. Immunol. and Immunopath. 30, 275-292.
16. Butchaiah, G., Rao, B.U., 1989. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1. Acta Virol. 33, 121-130.
17. Crowther, J.R., Farias, S., Carpenter, W.C., Samuel, A.R., 1993a. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple MAb escape mutants. J. Gen. Virol. 74, 1547-1553.
18. Crowther, J.R., Rowe, C.A., Butcher, R., 1993b. Characterization of monoclonal antibodies against a type SAT2 foot-and-mouth disease virus. Epidemiol. Infect. 111, 391-406.
19. Curry, S., Abu Ghazaleh, R., Blakemore, W., Fry, E., Jackson, T., King, A., Lea, S., Logan, D., Newman, J., Stuart, D., 1992. Crystallization and preliminary X-ray analysis of three serotypes of foot-and-mouth disease virus. J. Mol. Biol. 228, 1263-1268.
20. DiMarchi, R., Brooke, G., Gale, C., Cracknell, V., Doel, T., Mowat, N., 1986. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232, 639-641.
21. Finney, D.J., 1964. Statistical Methods in Biological Assay, 2nd ed. Hafner, New York, 571 pp.
22. Grubman, M.J., Morgan, D.O., Kendall, J., Baxt, B., 1985. Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells. J. Virol. 56, 120-126.
23. Hogle, J.M., Chow, M., Filman, D.J., 1985. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229, 1358-1365.
24. Kleid, D.G., Yansura, D., Small, B., Dowbenko, D.J., Moore, D.M., Grubman, M.J., McKercher, P.D., Morgan, D.O., Robertson, B.H., Bachrach, H.L., 1981. Cloned viral protein vaccine for foot-and-mouth disease: Responses in cattle and swine. Science 214, 1125-1129.
25. Martinez, M.A., Carrillo, C., Plana, J., Mascarella, R., Bergada, J., Palma, E.L., Domingo, E., Sobrino, F., 1988. Genetic and immunogenic variation among closely related isolates of foot-and-mouth disease virus. Gene 62, 75-84.
26. Mateu, M.G., Camarero, J.A., Gralt, E., Andrew, D., Domingo, E., 1995. Direct evaluation of the immuno-dominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206, 298-306.
27. Mateu, M.G., Martinez, M.A., Rocha, E., Andreu, D., Parejo, J., Giralt, F., Sobrino, D., Domingo, E., 1989. Implications of a quasi species genome structure: Effect of frequent naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc. Nat. Acad. Sci. USA 86, 5883-5887.
28. Mateu, M.G., Rocha, E., Vicente, O., Vayreda, F., Navalpotro, C., Andreu, D., Pedroso, E., Giralt, E., Enjuanes, L., Domingo, E., 1987. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Res. 8, 261-274.
29. McCahon, D., Crowther, J.R., Belsham, G.J., Kitson, J.D.A., Duchesne, M., Have, P., Meloen, R.H., Morgan, D.O., De Simone, F., 1989. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; Identification by single and multiple site monoclonal antibody resistant mutants. J. Gen. Virol. 70, 639-645.
30. Meloen, R.H., Puyk, W.C., Meijer, D.J.A., Lankhof, H., Posthumus, W.P.A., Schaaper, M.M., 1987. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus. J. Gen. Vriol. 68, 305-314.
31. Minor, P.D., Evans, D.M.A., Ferguson, M., Schild, G.C., Westrop, G., Almond, J.W., 1985. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J. Gen. Virol. 65, 1159-1165.
32. Morgan, D.O., Moore, D.M., 1990. Protection of cattle and swine against foot-and-mouth disease (FMD) with biosynthetic peptide vaccines. Am. J. Vet. Res. 51, 40-45.
33. Morrell, D.J., Mellor, E.J.C., Rowlands, D.J., Brown, F., 1987. Surface structure and RNA protein interactions of foot-and-mouth disease virus. J. Gen. Virol. 68, 1649-1658.
34. Page, G.S., Mosser, A.G., Hogle, J.M., Filman, D.J., Rueckert, R.R., Chow, M., 1988. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J. Virol. 62, 1781-1794.
35. Parry, N.R., Barnett, P.V., Ouldridge, E.J., Rowlands, D.J., Brown, F., 1989. Neutralizing epitopes of type-O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. J. Gen. Virol. 70, 1493-1503.
36. Polatnick, J., Bachrach, H.L., 1977. Growth of BHK cells for the production and purification of foot-and-mouth disease virus. In: Acton, R.T. (Ed.), Cell Culture and its Applications. Academic Press, New York, pp. 603-615.
37. Robertson, B.H., Moore, D.M., Grubman, M.J., Kleid, D.G., 1983. Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus. J. Virol. 46, 311-316.
38. Rossmann, M.G., Arnold, E., Erickson, J.W., Frankenberger, E.A., Griffith, J.P., Hecht, H.J., Johnson, J.E., Kamer, G., 1985. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (London) 317, 145-153.
39. Rweyemamu, M.M., Booth, J.C., Head, M., Pay, T.W.F., 1978. Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. J. Hyg. Camb. 81, 107-123.
40. Sherry, B., Mosser, A.G., Colonno, R.J., Rueckert, R.R., 1986. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human Rhinovirus 14. J. Virol. 57, 246-257.
41. Sobrino, F., Davila, M., Ortin, J., Domingo, E., 1983. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128, 310-318.
42. Stave, J.W., Card, J.L., Morgan, D.O., 1986. Analysis of foot-and-mouth disease virus type 01 Brugge neutralization epitopes using monoclonal antibodies. J. Gen. Virol. 67, 2083-2092.
43. Stave, J.W., Card, J.L., Morgan, D.O., Vakharia, V.N., 1988. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Virology 162, 21-29.
44. Stram, Y., Laor, O., Molad, T., Chai, D., Moore, D., Yadin, H., Becker, Y., 1994. Nucleotide sequence of the P1 region of serotype Asia-1 foot-and-mouth disease virus. Virus Genes 8, 275-278.
45. Strohmaier, K., Franze, R., Adam, K.H., 1982. Location and characterization of the antigenic protein of the FMDV immunizing protein. J. Gen. Virol. 59, 295-306.
46. Swaney, L.M., 1988. A continuous bovine kidney cell line for routine assays of foot-and-mouth disease virus. Vet. Microbiol. 18, 1-14.
47. Thomas, A.A.M., Woortmeijer, R.J., Puijk, W., Barteling, S.J., 1988. Antigenic sites on foot-and-mouth disease virus type A10. J. Virol. 62, 2782-2789.
48. VandeWoude, G.F., Swaney, J.B., Bachrach, H.L., 1972. Chemical and physical properties of foot-and-mouth disease virus genome. Biochem. Biophys. Res. Comm. 48, 1222-1229.
49. Vosloo, W., Knowles, N.J., Thomson, G.R., 1992. Genetic relationships between Southern African SAT-2 isolates of foot-and-mouth disease virus. Epidemiol. Infect. 109, 547-558.
50. Verdaguer, N., Mateu, M.G., Bravo, J., Tormo, I., Giralt, E., Andreu, D., Domingo, E., Fita, J., 1994. Crystallization and preliminary x-ray diffraction studies on a MAb FAb fragment against foot-and-mouth disease virus and of its complex with the main antigenic site peptide. Proteins Struct. Funct. Genet. 18, 201-203.
51. Wagner, G.G., Card, J.L., Cowan, K.M., 1970. Immunochemical studies of foot-and-mouth disease. VII Characterization of foot-and-mouth disease virus concentrated by polyethylene glycol precipitation. Arch. Virusforsch. 30, 343-352.
52. Xie, Q.C., McCahon, D., Crowther, J.R., Belsham, G.J., McCullough, K.C., 1987. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J. Gen. Virol. 68, 1637-1648.